Evaluation of cervical screening at treatment of a vulvovaginal atrophy in periand postmenopausal women
Objective. Determination of effective application of vaginal complex estriol 0,2 mg/progesteron 2 mg/Lactobacillus casei rhamnosus 2¥109 at women with a vulvovaginal atrophy in peri-and postmenopausal women with a evaluation of cervical screening. Materials and methods. 109 patients with a vulvovagi...
Main Authors: | T V Klinyshkova, I B Samosudova, O N Mironova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IP Berlin A.V.
2016-12-01
|
Series: | Гинекология |
Subjects: | |
Online Access: | https://gynecology.orscience.ru/2079-5831/article/viewFile/28584/pdf |
Similar Items
-
Treatment of postmenopausal vulvovaginal atrophy with estriol: a scientific update for 2014–2018
by: A. D. Makatsariya, et al.
Published: (2019-09-01) -
Dynamics of symptoms of genitourinary menopausal syndrome and the frequency of recurrence of lower urinary tract infection in women in periand postmenopausal patients with combined therapy with Trioginal®
by: D Yu Pushkar, et al.
Published: (2018-12-01) -
Differentiated approach to the treatment of genitourinary syndrome in perimenopausal women
by: Ю. П. Вдовиченко, et al.
Published: (2019-05-01) -
Vaginal dehydroepiandrosterone compared to other methods of treating
vaginal and vulvar atrophy associated with menopause
by: Wojciech Pięta, et al.
Published: (2021-01-01) -
Carbon Dioxide Laser Vulvovaginal Rejuvenation: A Systematic Review
by: Tassahil Messas, et al.
Published: (2021-06-01)